The purpose of this study is to check for effectiveness and safety in treating hot flashes associated with menopause. This is a phase 3 study.
14 months with 18 office visits; compensated with $75 per visit up t0 $1125
Blood work, ECG, mammogram, transvaginal ultrasound, endometrial biopsy, ediary.
- Women ages 40-65
- Confirmed menopause: absence of periods for at least 12 consecutive months -or- less than 6 months with an FSH result of 40 or less
- Moderate to severe hot flashes 7-8 times within 24 hours